Epizyme Stock Gains On Potential $310M Pact With HUTCHMED For Cancer-Focused Tazverik In Greater China
Auris Medical Stock Trading Higher After OligoPhore Technology Shows Tumor Inhibition In Animal Studies
Novartis' Neuroendocrine Tumors Targeted Radiotherapy Takes Small Hit on Clinically Relevant Overall Survival
Oric Pharma's ORIC-101 Shows Tumor Regression, Prolonged Stable Disease in Multiple Heavily Pretreated Tumors
Tumors Recent News
Phio Pharma's PH-762 Shows Encouraging Antitumor Efficacy In Preclinical Studies
Adaptimmune's HiT Program Can Potentially Kill Human Tumor Cells, Animal Study Shows
FDA Oncology Adcomm Votes To Keep Conditional Approval For Roche's Tecentriq In Place For Now
Hoth Therapeutics' mRNA Frame Shifting Therapeutic Inhibits Tumor Growth, Animal Study Shows
Phio Pharma's Intasyl Platform Shows Promising Tumor Control Activity In Animal Studies
Compugen To Test COM701, Opdivo Combination In Solid Tumor Settings
Theratechnologies' Peptide Conjugate Candidate For Solid Tumor Nabs Priority Review Tag In US, Shares Rally
Goldman Confident In Merck's Keytruda